Showing results (761-770 of 2,755) with videos related to
Sort By:
Pageof 276
Pharmacogenomics|July 26, 2022
Impact of the PEAR1 polymorphism on clinical outcomes in Chinese patients receiving dual antiplatelet therapy after percutaneous coronary interventionXinyuan Hu, Chaoxi Liu, Mingyou Zhang, et al.Pharmacogenomics|June 22, 2018
Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 alleleTingting Zhang, Ying Xiao, Yanxia Wang, et al.Pharmacogenomics|October 5, 2017
The pharmacogenomics of severe traumatic brain injurySolomon M Adams, Yvette P Conley, Amy K Wagner, et al.Pharmacogenomics|October 12, 2017
HLA-associated drug hypersensitivity and the prediction of adverse drug reactionsSimone Negrini, Laurent BecquemontPharmacogenomics|March 29, 2017
The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibitionFen Jiang, Jong-Yeol Choi, Ju-Hyun Lee, et al.Pharmacogenomics|March 29, 2017
Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot studyMamoonah Chaudhry, Marco Alessandrini, Jacobus Rademan, et al.Pharmacogenomics|January 14, 2017
Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patientsLei Ren, Mujian Teng, Tao Zhang, et al.Pharmacogenomics|January 14, 2017
Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish populationPär Hallberg, Matilda Persson, Tomas Axelsson, et al.Pharmacogenomics|September 28, 2016
Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcomeAurea Lima, Miguel Bernardes, Rita Azevedo, et al.Pharmacogenomics|August 2, 2019
Pharmacomicrobiomics informs clinical pharmacogenomicsTheodora Katsila, Angeliki Balasopoulou, Ioanna Tsagaraki, et al.Pageof 276